New incident report
Incident Report Number: 2021-0393
Registrant Reference Number: 2020-US-039218
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: MASSACHUSETTS
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-83
Product Name: Hartz UltraGuard Flea and Tick Collar for Cats and Kittens - White
Other (specify)
CollarYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Cat / Chat
Ragdoll
1
Female
3
10
lbs
Skin
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 28-Oct-2020, a 3 year old, 10 pound, neutered, female, Ragdoll cat, in unknown condition, with no known concomitant medical condition, had 1 Hartz UltraGuard Flea and Tick Collar for Cats and Kittens - White (Tetrachlorvinphos) placed around the neck by the animal owner. On 27-Oct-2020 the cat was also administered 1 tube of an Unspecified Hartz Flea and Tick Topical (unknown ingredient) via the topical route by the animal owner. On 29-Oct-2020 the cat exhibited agitation, pruritus, and rolling (abnormal behaviour). On 30-Oct-2020 the collar was removed and the cat was bathed with unspecified dish soap by the animal owner. On 31-Oct-2020 the cat exhibited anorexia and multiple seizures. The cat was not evaluated by a veterinarian and the signs continued. On 10-Nov-2020 the cat died. No further information was received in this case.
Death
Assessment: Tetrachlorvinphos is an organophosphate insecticide with a good margin of safety in cats following topical use. The initial signs of agitation and rolling were likely related to application of a collar in general if the cat was not used to wearing one. Anorexia and seizures began after the collar was removed and the cat was bathed. Prolonged anorexia and seizures progressing to death is not anticipated. Other causes including other exposures, infectious disease, underlying neurological or metabolic disease should be considered. Without veterinary evaluation and diagnostics, including necropsy, this case cannot be evaluated further. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.